It is thus important to bear in mind when assessing sexual dimorphism in CRC that the tissue microenvironment can modulate the action of estrogen and GPER in CRC malignancy and that the role of GPER in tumor progression differs depending on sex, tumor stage and microevironment. This evidence concerns the gene GPER1 and colorectal carcinoma.